VanEck Pharmaceutical ETF (PPH) IV/HV History
Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.
VanEck Pharmaceutical ETF (PPH) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $603.0M, listed on NASDAQ, carrying a beta of 0.46 to the broader market. VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals. public since 2000-02-01.
Snapshot as of May 15, 2026.
- Spot Price
- $100.86
- ATM IV
- 20.4%
- HV 20-Day
- 18.3%
- HV 60-Day
- 17.4%
- IV Rank
- 36.4%
- IV Percentile
- 50.8%
As of May 15, 2026, VanEck Pharmaceutical ETF (PPH) ATM implied volatility is 20.4%. 20-day realized volatility is 18.3%, producing an IV-HV spread of +2.1 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 36.4%.
How PPH iv/hv history Data Feeds Strategy Selection
Strategy selection on VanEck Pharmaceutical ETF options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 20.4% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.
Learn how implied vs realized volatility is reported and how to read the data →
Frequently asked PPH iv/hv history questions
- Is PPH options pricing rich or cheap right now?
- As of May 15, 2026, VanEck Pharmaceutical ETF (PPH) ATM IV is 20.4% against 20-day realized volatility of 18.3%. IV rank is 36.4%. PPH options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 2.1 vol points.
- What is the PPH variance risk premium?
- The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. PPH is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
- What does PPH IV rank mean for strategy selection?
- IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. PPH's current rank of 36.4% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.